N-(Phosphonacetyl)-l-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative group
- 1 January 1982
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 18 (1), 67-70
- https://doi.org/10.1016/0277-5379(82)90026-8
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- INITIAL CLINICAL-STUDY WITH N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) IN PATIENTS WITH ADVANCED CANCER1980
- PHASE-I TRIAL OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA)1980
- PHASE-I CLINICAL-STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA)1980
- m-AMSA and PALA: Two new agents in cancer chemotherapyCancer Chemotherapy and Pharmacology, 1979
- PHASE-I STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA)1979
- EFFECTS OF N-(PHOSPHONACETYL)-L-ASPARTATE ON MURINE TUMORS AND NORMAL TISSUES INVIVO AND INVITRO AND RELATIONSHIP OF SENSITIVITY TO RATE OF PROLIFERATION AND LEVEL OF ASPARTATE-TRANSCARBAMYLASE1978
- Chemotherapy of human colon cancer xenografts in athymic nude miceCancer, 1977
- Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomasCancer, 1977
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977
- Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-aspartate in vivoBiochemical Pharmacology, 1977